Early profound secondary autoimmune thrombocytopenia induced by clopidogrel in a patient with a coronary artery stent

References (1)

1. Li JJ, Xu B, Yang YJ, Chen JL, Qiao SB, Ma WH, Qin XW, Yao M, Liu HB, Wu YJ, Yuan JQ, Chen J, You SJ, Dai J, Xia R, Gao RL: Is there delayed restenosis in patients with coronary artery disease treated with sirolimus-eluting stent? Coron Artery Dis 2007; 18: 293-298 2. Guo YL, Li JJ, Yuan JQ, Qin XW, Zheng X, Mu CW, Hua YH: Profound thrombocytopenia induced by clopidogrel with a prior history of long-term safe administration. World J Cardiol 2010; 2 (6): 160-162 3. Best PJ, Mathew V, Markovic SN: Clopidogrel-associated autoimmune thrombocytopenic purpura. Catheter Cardiovasc Interv 2004; 62 (3): 339-340 4. Balamuthusamy S, Arora R: Hematologic adverse effects of clopidogrel. Am J Therap 2007; 14 (1): 106-112 5. Neunert C, Lim W, Crowther M, Cohen A, Solberg L, Crowther MA: The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia. Blood 2011; 117 (16): 4190-4207 6. Karpatkin S: Autoimmune (idiopathic) thrombocytopenic purpura. Lancet 1997; 24 (9064): 1531-1536